William Blair & Company
TARS icon

William Blair & Company’s Tarsus Pharmaceuticals TARS Stock Holding History

William Blair & Company’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
+22,053
New +$1.41M ﹤0.01% 873
2025
Q2 		– Sell
-11,416
Closed -$586K – 1899
2025
Q1 		$586K Sell
11,416
-15,814
-58% -$782K ﹤0.01% 1043
2024
Q4 		$1.51M Buy
+27,230
New +$1.24M ﹤0.01% 779

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

William Blair & Company's TARS Position: Q2 2026 in Review

William Blair & Company opened a new position in Tarsus Pharmaceuticals (TARS) in Q2 2026: 22,053 shares worth $1.39M. The stake represents ﹤0.01% of the portfolio and ranks #873 among its holdings. This is a return to the name: William Blair & Company previously reported a position in TARS as recently as Q1 2025.

William Blair & Company first reported a position in TARS in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.51M in Q4 2024. 256 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • William Blair & Company held 22,053 shares of Tarsus Pharmaceuticals worth $1.39M as of Q2 2026.
  • Tarsus Pharmaceuticals was a new William Blair & Company position in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #873 holding.
  • William Blair & Company first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • William Blair & Company's Tarsus Pharmaceuticals position peaked at $1.51M in Q4 2024.
  • 256 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.